Martin Bakht
@mkbakht
Cancer Biologist | Instructor |PCF YI | DoD PCRP Early Investigator | Dana-Farber Cancer Institute @mishabeltran Lab | Harvard Medical School | He/Him/His
ID: 1098517470
17-01-2013 15:51:23
499 Tweet
564 Takipçi
1,1K Takip Edilen
What a fun dinner with board members to start the holiday season :) Mayank Chugh (he/him) Alpen Ortug, PhD Kimia Sorouri, MD, MPH Martí Ortega-Ribera, PhD C. Dini Khairani, MD, MMSc Payel Ganguly @Wardiya_A_S José Luis We missed you Daisy Shu (she/her/hers) Le Hoang @rmd_neuro
New research in Nature Cancer reveals HOXB13 protein as key regulator of PSMA in #ProstateCancer and demonstrates PSMA control is complex. Read more ➡️ bit.ly/3nNwfH8 CC: Misha Beltran Dana-Farber Lank Center for Genitourinary Oncology
So excited to share our new paper Nature Cancer on PSMA regulation in AR-positive and AR-negative prostate cancer. Congratulations to lead author Martin Bakht Dana-Farber We are grateful for many wonderful collaborators Dana-Farber Lank Center for Genitourinary Oncology PCF Science nature.com/articles/s4301…
Couldn’t be prouder of the amazing work of Martin Bakht dissecting the landscape of PSMA heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer. Congratulations Misha Beltran! Porter lab nature.com/articles/s4301…
New insights into PSMA regulation. So glad to be part of this amazing project from Misha Beltran lab led by amazing Martin Bakht.
💫ONLINE NOW Nature Cancer “Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer” by Misha Beltran Martin Bakht & Co. Cancer at Nature Portfolio Read it here👇 nature.com/articles/s4301… rdcu.be/c9IYU
Proud to share our lab's new paper led by Yasutaka Yamada now out in Science Translational Medicine. Here we study the role of targeting DNA methylation in NEPC and RB1-deficient CRPC and co-targeting with B7-H3. Dana-Farber Lank Center for Genitourinary Oncology #BeltranLab science.org/doi/10.1126/sc…
Congratulations Andrew Goldstein and team! Honored to discuss your work in this News & views Nature Cell Biology with Martin Bakht Dana-Farber rdcu.be/dsJN3
💫NEW: Andrew Goldstein & co define #metabolic regulation of #prostate epithelial lineage identity and show that modulation of #lactate metabolism alters response to #antiandrogen therapy. 🎁Interested in reading more about the study? See comments below nature.com/articles/s4155…
Check out our new review in Nature Reviews Urology on biologic determinants of PSMA expression, regulation, and heterogeneity in prostate cancer led by Martin Bakht Dana-Farber Lank Center for Genitourinary Oncology PCF Science Link to paper: rdcu.be/dM7GF nature.com/articles/s4158…
Probably the best current review on PSMA expression ... congrats to Misha Beltran Martin Bakht nature.com/articles/s4158…
Proud to share our paper Journal of Clinical Investigation led by ShengYu Ku Dana-Farber with #GoodrichLab Roswell Park: Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer PCF Science jci.org/articles/view/…
Congratulations Balaji! Our new paper Nature Communications highlights the context specific role of EZH2 in prostate cancer. Thank you to many collaborators Myles Brown Rickman Lab and funding support Prostate Cancer Foundation DF/HCC National Cancer Institute #SPORE rdcu.be/dQo0P Dana-Farber #BeltranLab
🚨Aiming High: PSMA Expression in Treatment-naïve #prostatecancer 👏Martin Bakht & Misha Beltran provide editorial comments on our latest publication in European Urology "Given that PSMA PET scans are now routinely performed in newly diagnosed patients, this study is increasingly
It was an incredible experience presenting at #AACR25. Thank you to my mentor Misha Beltran and to PCF Science and CDMRP for their support. Grateful to DFCI for sharing!